From SNPedia
rs1801279 is a SNP in the NAT2 gene, potentially encoding a variant detoxifying protein known as an N-acetyltransferase, but which NAT2 variant depends on which other NAT2 SNPs were also inherited. See the discussion of the NAT2 gene for a more complete explanation.
The risk allele for this SNP is rs1801279(A).
| ? | (A;A) (A;G) (G;G) |
|---|
 |
| PharmGKB | PA161145093 |
| Name | NAT2:ARG64GLN, NAT2:191G>A, NAT2:M4, Included in NAT2*14 alleles(A-G). |
| Annotation | Homozygous A allele is slow acetylator phenotype (altered rates of metabolism of arylamines). May be associated with higher risk for bladder cancer and lower risk for colorectal cancer. |
| Gene | NAT2 |
| Featue | |
| Evidence | PubMed ID:10667461; PubMed ID:10971207; PubMed ID:17434923; PubMed ID:7668286; PubMed ID:7920692; PubMed ID:8102597; PubMed ID:9156695; Web Resource:http://louisville.edu/medschool/pharmacology/Human.NAT2.pdf |
| Drugs | |
| Diseases | |
| Curation Level | Curated |
